Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB

M. R. Maleki-Yazdi, C. K. Lewczuk, F. Kazim, J. M. Haddon, N. B. Choudry (Burlington, Canada)

Source: Annual Congress 2002 - Prevalence and costs of COPD
Session: Prevalence and costs of COPD
Session type: Thematic Poster Session
Number: 818
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. R. Maleki-Yazdi, C. K. Lewczuk, F. Kazim, J. M. Haddon, N. B. Choudry (Burlington, Canada). Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB. Eur Respir J 2002; 20: Suppl. 38, 818

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002

GOLD stage 0 and risk of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 352s
Year: 2003

Impact of comorbidities on survival of patients with COPD according to GOLD stages
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011


Stage 0 in GOLD does not predict future clinical COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 401s
Year: 2002

Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003

Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results
Source: Eur Respir J 2005; 26: Suppl. 49, 69s
Year: 2005

Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II
Source: Eur Respir J 2005; 26: Suppl. 49, 434s
Year: 2005

Effects of tiotropium on lung volumes during exercise in GOLD stage II to IV COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 171s
Year: 2006

COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Quality of life, stage severity and COPD
Source: Eur Respir J 2009; 33: 953-955
Year: 2009


Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015

Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006

The stage of severity, BODE-index and quality of life (QL) at COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 808s
Year: 2006

Total mortality risks in relation to the GOLD stages in a long term follow-up - a special analysis of GOLD stage 0
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004


Quality of life (QoL) in patients with stage IIIB NSCLC: Personal evaluation
Source: Eur Respir J 2002; 20: Suppl. 38, 271s
Year: 2002

Impact of symptomatology in patients with GOLD stage I COPD
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010

Relationship between quality of life and severity of COPD according to GOLD classification
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004

Quality of life in patients with stage IIIb NSCLC: personal evaluation
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002

The effect of changing GOLD severity stage on long-term mortality in COPD
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

GOLD stage in COPD not predictive of health status outcomes before and after pulmonary rehabilitation
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010